1 not yet recruiting, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 1, Unknown 1 |
Follow Esophageal Squamous Cell Carcinoma: new trials by email Literature Review of Esophageal Squamous Cell Carcinoma trials Research Report on Esophageal Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma Serplulimab Combined With Nab-paclitaxel and Cisplatin, nab-paclitaxel，Cisplatin - Esophageal Squamous Cell Carcinoma | Phase 4 | Not yet recruiting | Yang Jianjun, PhD | 80 | 2024-05-01 | 2024-04-29 |
| Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES) Tislelizumab + cisplatin + paclitaxel, Tislelizumab + radiotherapy - Esophageal Squamous Cell Carcinoma | Phase 4 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 32 | 2022-10-10 | 2023-06-29 |
Carcinoma (2) · Carcinoma, Squamous Cell (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Esophageal Diseases (2) · Esophageal Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Head and Neck Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Squamous Cell (2)
Cisplatin (2) · 130-nm albumin-bound paclitaxel (1) · Paclitaxel (1) · Radiotherapy (1) · tislelizumab (1)
First Affiliated Hospital Xi'an Jiaotong University (1) · Yang Jianjun, PhD (1)
China (1)
Junke Fu (1)